C-reactive protein and venous thromboembolism: causal or casual association? (Q34130906)

31 July 2017

1 reference

title

C-reactive protein and venous thromboembolism: causal or casual association? (English)

1 reference

31 July 2017

venous thromboembolism

1 reference

2

Emmanuel J Favaloro

1 reference

31 July 2017

1

Giuseppe Lippi

1 reference

31 July 2017

4

Massimo Franchini

1 reference

31 July 2017

3

Martina Montagnana

1 reference

31 July 2017

13 August 2010

1 reference

Clinical Chemistry and Laboratory Medicine

31 July 2017

1 reference

31 July 2017

48

1 reference

31 July 2017

12

1 reference

31 July 2017

1693-1701

1 reference

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

31 July 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

The liver as the site of C-reactive protein formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein: history and revival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Allelic spectrum of the natural variation in CRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Proinflammatory cytokines in CRP baseline regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein: structural biology and host defense function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Function of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Human C-reactive protein: expression, structure, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein and coronary disease: is there a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

A systematic review of the association between circulating concentrations of C reactive protein and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein and coronary heart disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Use of statins and the subsequent development of deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Venous and arterial thrombosis: different sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Statins, fibrates, and venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Inflammation, the acute phase response and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Effects of C-reactive protein (CRP) on platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

The significance of endothelial heterogeneity in thrombosis and hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein isoforms differ in their effects on thrombus growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Von Willebrand factor: another janus-faced hemostasis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Milestones and perspectives in coagulation and hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Pathogenesis of venous thromboembolism: when the cup runneth over

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position −675 of the PAI-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.335

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.335

1 reference

31 July 2017

1 reference

PubMed ID

20704541